nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—CYP1A2—Pentoxifylline—systemic scleroderma	0.122	0.512	CbGbCtD
Guanabenz—CYP1A2—Leflunomide—systemic scleroderma	0.117	0.488	CbGbCtD
Guanabenz—Headache—Mometasone—systemic scleroderma	0.000575	0.000755	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000574	0.000754	CcSEcCtD
Guanabenz—Fatigue—Leflunomide—systemic scleroderma	0.000573	0.000753	CcSEcCtD
Guanabenz—Oedema—Lisinopril—systemic scleroderma	0.000571	0.00075	CcSEcCtD
Guanabenz—Pruritus—Captopril—systemic scleroderma	0.00057	0.000749	CcSEcCtD
Guanabenz—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000569	0.000748	CcSEcCtD
Guanabenz—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000569	0.000747	CcSEcCtD
Guanabenz—Pain—Leflunomide—systemic scleroderma	0.000568	0.000746	CcSEcCtD
Guanabenz—Constipation—Leflunomide—systemic scleroderma	0.000568	0.000746	CcSEcCtD
Guanabenz—Infection—Lisinopril—systemic scleroderma	0.000567	0.000745	CcSEcCtD
Guanabenz—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000566	0.000744	CcSEcCtD
Guanabenz—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000565	0.000742	CcSEcCtD
Guanabenz—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00074	CcSEcCtD
Guanabenz—Shock—Lisinopril—systemic scleroderma	0.000562	0.000738	CcSEcCtD
Guanabenz—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00056	0.000736	CcSEcCtD
Guanabenz—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000559	0.000734	CcSEcCtD
Guanabenz—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000558	0.000733	CcSEcCtD
Guanabenz—Tachycardia—Lisinopril—systemic scleroderma	0.000557	0.000732	CcSEcCtD
Guanabenz—Abdominal pain—Azathioprine—systemic scleroderma	0.000556	0.000731	CcSEcCtD
Guanabenz—Body temperature increased—Azathioprine—systemic scleroderma	0.000556	0.000731	CcSEcCtD
Guanabenz—Skin disorder—Lisinopril—systemic scleroderma	0.000554	0.000729	CcSEcCtD
Guanabenz—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000553	0.000726	CcSEcCtD
Guanabenz—Diarrhoea—Captopril—systemic scleroderma	0.000552	0.000725	CcSEcCtD
Guanabenz—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000551	0.000724	CcSEcCtD
Guanabenz—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00055	0.000722	CcSEcCtD
Guanabenz—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000721	CcSEcCtD
Guanabenz—Feeling abnormal—Leflunomide—systemic scleroderma	0.000547	0.000719	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000547	0.000719	CcSEcCtD
Guanabenz—Fatigue—Mycophenolic acid—systemic scleroderma	0.000546	0.000718	CcSEcCtD
Guanabenz—Nausea—Mometasone—systemic scleroderma	0.000545	0.000716	CcSEcCtD
Guanabenz—Anorexia—Lisinopril—systemic scleroderma	0.000544	0.000715	CcSEcCtD
Guanabenz—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000543	0.000714	CcSEcCtD
Guanabenz—Weight increased—Prednisone—systemic scleroderma	0.000543	0.000713	CcSEcCtD
Guanabenz—Pain—Mycophenolic acid—systemic scleroderma	0.000542	0.000712	CcSEcCtD
Guanabenz—Constipation—Mycophenolic acid—systemic scleroderma	0.000542	0.000712	CcSEcCtD
Guanabenz—Weight decreased—Prednisone—systemic scleroderma	0.000539	0.000709	CcSEcCtD
Guanabenz—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000539	0.000708	CcSEcCtD
Guanabenz—Hyperglycaemia—Prednisone—systemic scleroderma	0.000538	0.000707	CcSEcCtD
Guanabenz—Cough—Mycophenolate mofetil—systemic scleroderma	0.000535	0.000703	CcSEcCtD
Guanabenz—Hypotension—Lisinopril—systemic scleroderma	0.000533	0.000701	CcSEcCtD
Guanabenz—Dizziness—Captopril—systemic scleroderma	0.000533	0.0007	CcSEcCtD
Guanabenz—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000532	0.000699	CcSEcCtD
Guanabenz—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000529	0.000695	CcSEcCtD
Guanabenz—Urticaria—Leflunomide—systemic scleroderma	0.000528	0.000693	CcSEcCtD
Guanabenz—Abdominal pain—Leflunomide—systemic scleroderma	0.000525	0.00069	CcSEcCtD
Guanabenz—Body temperature increased—Leflunomide—systemic scleroderma	0.000525	0.00069	CcSEcCtD
Guanabenz—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000522	0.000686	CcSEcCtD
Guanabenz—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000686	CcSEcCtD
Guanabenz—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000686	CcSEcCtD
Guanabenz—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000522	0.000686	CcSEcCtD
Guanabenz—Breast disorder—Methotrexate—systemic scleroderma	0.000521	0.000684	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00052	0.000683	CcSEcCtD
Guanabenz—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00052	0.000683	CcSEcCtD
Guanabenz—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000519	0.000682	CcSEcCtD
Guanabenz—Hypersensitivity—Azathioprine—systemic scleroderma	0.000518	0.000681	CcSEcCtD
Guanabenz—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000518	0.000681	CcSEcCtD
Guanabenz—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000515	0.000677	CcSEcCtD
Guanabenz—Paraesthesia—Lisinopril—systemic scleroderma	0.000513	0.000673	CcSEcCtD
Guanabenz—Vomiting—Captopril—systemic scleroderma	0.000513	0.000673	CcSEcCtD
Guanabenz—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00067	CcSEcCtD
Guanabenz—Dyspnoea—Lisinopril—systemic scleroderma	0.000509	0.000669	CcSEcCtD
Guanabenz—Rash—Captopril—systemic scleroderma	0.000508	0.000668	CcSEcCtD
Guanabenz—Dermatitis—Captopril—systemic scleroderma	0.000508	0.000667	CcSEcCtD
Guanabenz—Headache—Captopril—systemic scleroderma	0.000505	0.000663	CcSEcCtD
Guanabenz—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000504	0.000663	CcSEcCtD
Guanabenz—Dyspepsia—Lisinopril—systemic scleroderma	0.000502	0.00066	CcSEcCtD
Guanabenz—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000501	0.000658	CcSEcCtD
Guanabenz—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000501	0.000658	CcSEcCtD
Guanabenz—Oedema—Mycophenolate mofetil—systemic scleroderma	0.0005	0.000657	CcSEcCtD
Guanabenz—Infection—Mycophenolate mofetil—systemic scleroderma	0.000497	0.000653	CcSEcCtD
Guanabenz—Decreased appetite—Lisinopril—systemic scleroderma	0.000496	0.000652	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000493	0.000648	CcSEcCtD
Guanabenz—Fatigue—Lisinopril—systemic scleroderma	0.000492	0.000647	CcSEcCtD
Guanabenz—Shock—Mycophenolate mofetil—systemic scleroderma	0.000492	0.000647	CcSEcCtD
Guanabenz—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00049	0.000644	CcSEcCtD
Guanabenz—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00049	0.000643	CcSEcCtD
Guanabenz—Hypersensitivity—Leflunomide—systemic scleroderma	0.000489	0.000643	CcSEcCtD
Guanabenz—Constipation—Lisinopril—systemic scleroderma	0.000488	0.000641	CcSEcCtD
Guanabenz—Pain—Lisinopril—systemic scleroderma	0.000488	0.000641	CcSEcCtD
Guanabenz—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000488	0.000641	CcSEcCtD
Guanabenz—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000638	CcSEcCtD
Guanabenz—Diarrhoea—Azathioprine—systemic scleroderma	0.000481	0.000632	CcSEcCtD
Guanabenz—Haemoglobin—Prednisone—systemic scleroderma	0.00048	0.00063	CcSEcCtD
Guanabenz—Nausea—Captopril—systemic scleroderma	0.000479	0.000629	CcSEcCtD
Guanabenz—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000478	0.000628	CcSEcCtD
Guanabenz—Haemorrhage—Prednisone—systemic scleroderma	0.000477	0.000627	CcSEcCtD
Guanabenz—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.000626	CcSEcCtD
Guanabenz—Asthenia—Leflunomide—systemic scleroderma	0.000477	0.000626	CcSEcCtD
Guanabenz—Feeling abnormal—Lisinopril—systemic scleroderma	0.00047	0.000618	CcSEcCtD
Guanabenz—Pruritus—Leflunomide—systemic scleroderma	0.00047	0.000618	CcSEcCtD
Guanabenz—Connective tissue disorder—Prednisone—systemic scleroderma	0.000469	0.000616	CcSEcCtD
Guanabenz—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000467	0.000614	CcSEcCtD
Guanabenz—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000467	0.000613	CcSEcCtD
Guanabenz—Dizziness—Azathioprine—systemic scleroderma	0.000465	0.000611	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000463	0.000608	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000456	0.000599	CcSEcCtD
Guanabenz—Asthenia—Mycophenolic acid—systemic scleroderma	0.000455	0.000597	CcSEcCtD
Guanabenz—Diarrhoea—Leflunomide—systemic scleroderma	0.000455	0.000597	CcSEcCtD
Guanabenz—Urticaria—Lisinopril—systemic scleroderma	0.000453	0.000596	CcSEcCtD
Guanabenz—Abdominal pain—Lisinopril—systemic scleroderma	0.000451	0.000593	CcSEcCtD
Guanabenz—Body temperature increased—Lisinopril—systemic scleroderma	0.000451	0.000593	CcSEcCtD
Guanabenz—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000449	0.00059	CcSEcCtD
Guanabenz—Pruritus—Mycophenolic acid—systemic scleroderma	0.000448	0.000589	CcSEcCtD
Guanabenz—Vomiting—Azathioprine—systemic scleroderma	0.000447	0.000588	CcSEcCtD
Guanabenz—Eye disorder—Prednisone—systemic scleroderma	0.000446	0.000586	CcSEcCtD
Guanabenz—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000446	0.000586	CcSEcCtD
Guanabenz—Infestation NOS—Methotrexate—systemic scleroderma	0.000444	0.000584	CcSEcCtD
Guanabenz—Infestation—Methotrexate—systemic scleroderma	0.000444	0.000584	CcSEcCtD
Guanabenz—Rash—Azathioprine—systemic scleroderma	0.000444	0.000583	CcSEcCtD
Guanabenz—Dermatitis—Azathioprine—systemic scleroderma	0.000443	0.000582	CcSEcCtD
Guanabenz—Headache—Azathioprine—systemic scleroderma	0.000441	0.000579	CcSEcCtD
Guanabenz—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.000578	CcSEcCtD
Guanabenz—Dizziness—Leflunomide—systemic scleroderma	0.000439	0.000577	CcSEcCtD
Guanabenz—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000435	0.000571	CcSEcCtD
Guanabenz—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000434	0.00057	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000432	0.000567	CcSEcCtD
Guanabenz—Immune system disorder—Prednisone—systemic scleroderma	0.000431	0.000566	CcSEcCtD
Guanabenz—Pain—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000562	CcSEcCtD
Guanabenz—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000428	0.000562	CcSEcCtD
Guanabenz—Vomiting—Leflunomide—systemic scleroderma	0.000422	0.000555	CcSEcCtD
Guanabenz—Hypersensitivity—Lisinopril—systemic scleroderma	0.000421	0.000553	CcSEcCtD
Guanabenz—Dizziness—Mycophenolic acid—systemic scleroderma	0.000419	0.000551	CcSEcCtD
Guanabenz—Rash—Leflunomide—systemic scleroderma	0.000419	0.00055	CcSEcCtD
Guanabenz—Dermatitis—Leflunomide—systemic scleroderma	0.000418	0.00055	CcSEcCtD
Guanabenz—Nausea—Azathioprine—systemic scleroderma	0.000418	0.000549	CcSEcCtD
Guanabenz—Headache—Leflunomide—systemic scleroderma	0.000416	0.000547	CcSEcCtD
Guanabenz—Erythema—Prednisone—systemic scleroderma	0.000415	0.000546	CcSEcCtD
Guanabenz—Malnutrition—Prednisone—systemic scleroderma	0.000415	0.000546	CcSEcCtD
Guanabenz—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000412	0.000542	CcSEcCtD
Guanabenz—Asthenia—Lisinopril—systemic scleroderma	0.00041	0.000538	CcSEcCtD
Guanabenz—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000409	0.000537	CcSEcCtD
Guanabenz—Pruritus—Lisinopril—systemic scleroderma	0.000404	0.000531	CcSEcCtD
Guanabenz—Vomiting—Mycophenolic acid—systemic scleroderma	0.000403	0.000529	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—systemic scleroderma	0.000401	0.000527	CcSEcCtD
Guanabenz—Rash—Mycophenolic acid—systemic scleroderma	0.0004	0.000525	CcSEcCtD
Guanabenz—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000399	0.000525	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—systemic scleroderma	0.000399	0.000524	CcSEcCtD
Guanabenz—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000397	0.000522	CcSEcCtD
Guanabenz—Headache—Mycophenolic acid—systemic scleroderma	0.000397	0.000522	CcSEcCtD
Guanabenz—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000519	CcSEcCtD
Guanabenz—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000395	0.000519	CcSEcCtD
Guanabenz—Nausea—Leflunomide—systemic scleroderma	0.000395	0.000518	CcSEcCtD
Guanabenz—Vision blurred—Prednisone—systemic scleroderma	0.000392	0.000514	CcSEcCtD
Guanabenz—Diarrhoea—Lisinopril—systemic scleroderma	0.000391	0.000513	CcSEcCtD
Guanabenz—Ill-defined disorder—Prednisone—systemic scleroderma	0.000385	0.000506	CcSEcCtD
Guanabenz—Anaemia—Prednisone—systemic scleroderma	0.000384	0.000504	CcSEcCtD
Guanabenz—Agitation—Prednisone—systemic scleroderma	0.000382	0.000502	CcSEcCtD
Guanabenz—Angioedema—Prednisone—systemic scleroderma	0.00038	0.000499	CcSEcCtD
Guanabenz—Dizziness—Lisinopril—systemic scleroderma	0.000377	0.000496	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—systemic scleroderma	0.000377	0.000495	CcSEcCtD
Guanabenz—Nausea—Mycophenolic acid—systemic scleroderma	0.000376	0.000495	CcSEcCtD
Guanabenz—Malaise—Prednisone—systemic scleroderma	0.000375	0.000492	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—systemic scleroderma	0.000373	0.00049	CcSEcCtD
Guanabenz—Syncope—Prednisone—systemic scleroderma	0.000373	0.000489	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—systemic scleroderma	0.000372	0.000489	CcSEcCtD
Guanabenz—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000484	CcSEcCtD
Guanabenz—Loss of consciousness—Prednisone—systemic scleroderma	0.000365	0.00048	CcSEcCtD
Guanabenz—Vomiting—Lisinopril—systemic scleroderma	0.000363	0.000477	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—systemic scleroderma	0.00036	0.000473	CcSEcCtD
Guanabenz—Rash—Lisinopril—systemic scleroderma	0.00036	0.000473	CcSEcCtD
Guanabenz—Dermatitis—Lisinopril—systemic scleroderma	0.00036	0.000472	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000359	0.000472	CcSEcCtD
Guanabenz—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000359	0.000471	CcSEcCtD
Guanabenz—Hypertension—Prednisone—systemic scleroderma	0.000359	0.000471	CcSEcCtD
Guanabenz—Chills—Methotrexate—systemic scleroderma	0.000358	0.00047	CcSEcCtD
Guanabenz—Headache—Lisinopril—systemic scleroderma	0.000358	0.00047	CcSEcCtD
Guanabenz—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000465	CcSEcCtD
Guanabenz—Arthralgia—Prednisone—systemic scleroderma	0.000354	0.000465	CcSEcCtD
Guanabenz—Myalgia—Prednisone—systemic scleroderma	0.000354	0.000465	CcSEcCtD
Guanabenz—Anxiety—Prednisone—systemic scleroderma	0.000352	0.000463	CcSEcCtD
Guanabenz—Discomfort—Prednisone—systemic scleroderma	0.000349	0.000459	CcSEcCtD
Guanabenz—Erythema—Methotrexate—systemic scleroderma	0.000347	0.000456	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—systemic scleroderma	0.000347	0.000456	CcSEcCtD
Guanabenz—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00045	CcSEcCtD
Guanabenz—Nausea—Lisinopril—systemic scleroderma	0.000339	0.000445	CcSEcCtD
Guanabenz—Oedema—Prednisone—systemic scleroderma	0.000339	0.000445	CcSEcCtD
Guanabenz—Infection—Prednisone—systemic scleroderma	0.000337	0.000443	CcSEcCtD
Guanabenz—Back pain—Methotrexate—systemic scleroderma	0.000336	0.000441	CcSEcCtD
Guanabenz—Shock—Prednisone—systemic scleroderma	0.000334	0.000438	CcSEcCtD
Guanabenz—Nervous system disorder—Prednisone—systemic scleroderma	0.000332	0.000437	CcSEcCtD
Guanabenz—Tachycardia—Prednisone—systemic scleroderma	0.000331	0.000435	CcSEcCtD
Guanabenz—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000435	CcSEcCtD
Guanabenz—Skin disorder—Prednisone—systemic scleroderma	0.000329	0.000433	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—systemic scleroderma	0.000327	0.00043	CcSEcCtD
Guanabenz—Anorexia—Prednisone—systemic scleroderma	0.000323	0.000425	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000322	0.000423	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—systemic scleroderma	0.000321	0.000422	CcSEcCtD
Guanabenz—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000418	CcSEcCtD
Guanabenz—Rash—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000414	CcSEcCtD
Guanabenz—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000414	CcSEcCtD
Guanabenz—Headache—Mycophenolate mofetil—systemic scleroderma	0.000313	0.000412	CcSEcCtD
Guanabenz—Malaise—Methotrexate—systemic scleroderma	0.000313	0.000411	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—systemic scleroderma	0.000311	0.000408	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000309	0.000406	CcSEcCtD
Guanabenz—Paraesthesia—Prednisone—systemic scleroderma	0.000304	0.0004	CcSEcCtD
Guanabenz—Cough—Methotrexate—systemic scleroderma	0.000303	0.000398	CcSEcCtD
Guanabenz—Dyspepsia—Prednisone—systemic scleroderma	0.000298	0.000392	CcSEcCtD
Guanabenz—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00039	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—systemic scleroderma	0.000296	0.000388	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—systemic scleroderma	0.000296	0.000388	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—systemic scleroderma	0.000296	0.000388	CcSEcCtD
Guanabenz—Decreased appetite—Prednisone—systemic scleroderma	0.000295	0.000387	CcSEcCtD
Guanabenz—Fatigue—Prednisone—systemic scleroderma	0.000292	0.000384	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—systemic scleroderma	0.000292	0.000384	CcSEcCtD
Guanabenz—Constipation—Prednisone—systemic scleroderma	0.00029	0.000381	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—systemic scleroderma	0.000286	0.000375	CcSEcCtD
Guanabenz—Infection—Methotrexate—systemic scleroderma	0.000281	0.00037	CcSEcCtD
Guanabenz—Feeling abnormal—Prednisone—systemic scleroderma	0.000279	0.000367	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—systemic scleroderma	0.000278	0.000365	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000277	0.000364	CcSEcCtD
Guanabenz—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000277	0.000364	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—systemic scleroderma	0.000275	0.000362	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—systemic scleroderma	0.00027	0.000355	CcSEcCtD
Guanabenz—Urticaria—Prednisone—systemic scleroderma	0.000269	0.000354	CcSEcCtD
Guanabenz—Body temperature increased—Prednisone—systemic scleroderma	0.000268	0.000352	CcSEcCtD
Guanabenz—Abdominal pain—Prednisone—systemic scleroderma	0.000268	0.000352	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—systemic scleroderma	0.000265	0.000348	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000258	0.000339	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—systemic scleroderma	0.000254	0.000334	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—systemic scleroderma	0.000253	0.000332	CcSEcCtD
Guanabenz—Hypersensitivity—Prednisone—systemic scleroderma	0.00025	0.000328	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—systemic scleroderma	0.000249	0.000328	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—systemic scleroderma	0.000246	0.000324	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000245	0.000321	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—systemic scleroderma	0.000244	0.000321	CcSEcCtD
Guanabenz—Asthenia—Prednisone—systemic scleroderma	0.000243	0.00032	CcSEcCtD
Guanabenz—Pain—Methotrexate—systemic scleroderma	0.000242	0.000318	CcSEcCtD
Guanabenz—Pruritus—Prednisone—systemic scleroderma	0.00024	0.000315	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—systemic scleroderma	0.000233	0.000307	CcSEcCtD
Guanabenz—Diarrhoea—Prednisone—systemic scleroderma	0.000232	0.000305	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000232	0.000304	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—systemic scleroderma	0.000225	0.000296	CcSEcCtD
Guanabenz—Dizziness—Prednisone—systemic scleroderma	0.000224	0.000295	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—systemic scleroderma	0.000224	0.000294	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—systemic scleroderma	0.000224	0.000294	CcSEcCtD
Guanabenz—Vomiting—Prednisone—systemic scleroderma	0.000216	0.000283	CcSEcCtD
Guanabenz—Rash—Prednisone—systemic scleroderma	0.000214	0.000281	CcSEcCtD
Guanabenz—Dermatitis—Prednisone—systemic scleroderma	0.000214	0.000281	CcSEcCtD
Guanabenz—Headache—Prednisone—systemic scleroderma	0.000212	0.000279	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—systemic scleroderma	0.000209	0.000274	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—systemic scleroderma	0.000203	0.000267	CcSEcCtD
Guanabenz—Nausea—Prednisone—systemic scleroderma	0.000201	0.000265	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—systemic scleroderma	0.0002	0.000263	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—systemic scleroderma	0.000194	0.000255	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—systemic scleroderma	0.000187	0.000246	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—systemic scleroderma	0.00018	0.000237	CcSEcCtD
Guanabenz—Rash—Methotrexate—systemic scleroderma	0.000179	0.000235	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—systemic scleroderma	0.000178	0.000235	CcSEcCtD
Guanabenz—Headache—Methotrexate—systemic scleroderma	0.000178	0.000233	CcSEcCtD
Guanabenz—Nausea—Methotrexate—systemic scleroderma	0.000168	0.000221	CcSEcCtD
